These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 2112489

  • 21. Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.
    Yun BS, Seong SJ, Cha DH, Kim JY, Kim ML, Shim JY, Park JE.
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():62-7. PubMed ID: 26093349
    [Abstract] [Full Text] [Related]

  • 22. Estrogen and progesterone receptor content of GnRH analogue pretreated and untreated uterine leiomyomata.
    Regidor PA, Schmidt M, Callies R, Kato K, Schindler AE.
    Eur J Obstet Gynecol Reprod Biol; 1995 Nov; 63(1):69-73. PubMed ID: 8674569
    [Abstract] [Full Text] [Related]

  • 23. Rapid loss of oestrogen and progesterone receptors in human leiomyoma and myometrial explant cultures.
    Severino MF, Murray MJ, Brandon DD, Clinton GM, Burry KA, Novy MJ.
    Mol Hum Reprod; 1996 Nov; 2(11):823-8. PubMed ID: 9237221
    [Abstract] [Full Text] [Related]

  • 24. Gonadotropin-releasing hormone analogues inhibit leiomyoma extracellular matrix despite presence of gonadal hormones.
    Malik M, Britten J, Cox J, Patel A, Catherino WH.
    Fertil Steril; 2016 Jan; 105(1):214-24. PubMed ID: 26409322
    [Abstract] [Full Text] [Related]

  • 25. Different expression of estrogen receptors alpha and beta in human myometrium and leiomyoma during the proliferative phase of the menstrual cycle and after GnRHa treatment.
    Wang H, Wu X, Englund K, Masironi B, Eriksson H, Sahlin L.
    Gynecol Endocrinol; 2001 Dec; 15(6):443-52. PubMed ID: 11826769
    [Abstract] [Full Text] [Related]

  • 26. Expression profiles of E/P receptors and fibrosis in GnRHa-treated and -untreated women with different uterine leiomyomas.
    Khan KN, Fujishita A, Koshiba A, Ogawa K, Mori T, Ogi H, Itoh K, Teramukai S, Kitawaki J.
    PLoS One; 2020 Dec; 15(11):e0242246. PubMed ID: 33186388
    [Abstract] [Full Text] [Related]

  • 27. Immunoexpression of Steroid Hormone Receptors and Proliferation Markers in Uterine Leiomyoma and Normal Myometrial Tissues from the Miniature Pig, Sus scrofa.
    Mozzachio K, Moore AB, Kissling GE, Dixon D.
    Toxicol Pathol; 2016 Apr; 44(3):450-7. PubMed ID: 26692562
    [Abstract] [Full Text] [Related]

  • 28. Estrogen and progesterone receptor content of enucleated uterine myomata after luteinizing hormone-releasing hormone. Analogue depot therapy.
    Cirkel U, Ochs H, Roehl A, Schneider HP.
    Acta Obstet Gynecol Scand; 1994 Apr; 73(4):328-32. PubMed ID: 8160541
    [Abstract] [Full Text] [Related]

  • 29. Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin-releasing hormone agonist.
    Friedman AJ, Barbieri RL, Benacerraf BR, Schiff I.
    Fertil Steril; 1987 Oct; 48(4):560-4. PubMed ID: 3115833
    [Abstract] [Full Text] [Related]

  • 30. A prospective randomized study to evaluate leuprolide acetate treatment before laparoscopic myomectomy: efficacy and ultrasonographic predictors.
    Zullo F, Pellicano M, De Stefano R, Zupi E, Mastrantonio P.
    Am J Obstet Gynecol; 1998 Jan; 178(1 Pt 1):108-12. PubMed ID: 9465812
    [Abstract] [Full Text] [Related]

  • 31. A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata.
    Friedman AJ, Harrison-Atlas D, Barbieri RL, Benacerraf B, Gleason R, Schiff I.
    Fertil Steril; 1989 Feb; 51(2):251-6. PubMed ID: 2492232
    [Abstract] [Full Text] [Related]

  • 32. Oestrogen deficiency causes DNA damage in uterine leiomyoma cells: a possible mechanism for shrinkage of fibroids by GnRH agonists.
    Cheng YM, Chou CY, Huang SC, Lin HC.
    BJOG; 2001 Jan; 108(1):95-102. PubMed ID: 11213012
    [Abstract] [Full Text] [Related]

  • 33. Randomized double-blind study evaluating the efficacy on uterine fibroids shrinkage and on intra-operative blood loss of different length of leuprolide acetate depot treatment before myomectomy.
    Jasonni VM, D'Anna R, Mancuso A, Caruso C, Corrado F, Leonardi I.
    Acta Obstet Gynecol Scand; 2001 Oct; 80(10):956-8. PubMed ID: 11580742
    [Abstract] [Full Text] [Related]

  • 34. Gene expression and tissue concentrations of IGF-I in human myometrium and fibroids under different hormonal conditions.
    Englund K, Lindblom B, Carlström K, Gustavsson I, Sjöblom P, Blanck A.
    Mol Hum Reprod; 2000 Oct; 6(10):915-20. PubMed ID: 11006320
    [Abstract] [Full Text] [Related]

  • 35. A comparative study of the effect of raloxifene and gosereline on uterine leiomyoma volume changes and estrogen receptor, progesterone receptor, bcl-2 and p53 expression immunohistochemically in premenopausal women.
    Baytur YB, Ozbilgin K, Cilaker S, Lacin S, Kurtul O, Oruc S, Koyuncu FM.
    Eur J Obstet Gynecol Reprod Biol; 2007 Nov; 135(1):94-103. PubMed ID: 16973256
    [Abstract] [Full Text] [Related]

  • 36. [GnRH-analogs in the therapy of uterine myomatosis].
    Wieacker P, Geisthövel F, Adelberger V, Breckwoldt M.
    Ther Umsch; 1990 Dec; 47(12):951-7. PubMed ID: 2151405
    [Abstract] [Full Text] [Related]

  • 37. Experience with leuprorelin acetate depot in the treatment of fibroids: a German multicentre study.
    Cirkel U, Ochs H, Schneider HP, Mettler L, Mayer-Eichberger D, Schindler AE, Bühler K, Winkler U, Zahradnik HP, Künzig HJ.
    Clin Ther; 1992 Dec; 14 Suppl A():37-50. PubMed ID: 1606593
    [Abstract] [Full Text] [Related]

  • 38. Fasting serum growth hormone and insulin-like growth factor-I and -II concentrations in women with leiomyomata uteri treated with leuprolide acetate or placebo.
    Friedman AJ, Rein MS, Pandian MR, Barbieri RL.
    Fertil Steril; 1990 Feb; 53(2):250-3. PubMed ID: 2105242
    [Abstract] [Full Text] [Related]

  • 39. Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas.
    Ishihara H, Kitawaki J, Kado N, Koshiba H, Fushiki S, Honjo H.
    Fertil Steril; 2003 Mar; 79 Suppl 1():735-42. PubMed ID: 12620485
    [Abstract] [Full Text] [Related]

  • 40. Metachromasia of the endocervical epithelium in women treated with gonadotropin releasing hormone agonist.
    Morimura M, Ishiko O, Honda KI, Sumi T, Kawamura N, Wakasa K, Haba T, Ogita S.
    Int J Mol Med; 2001 Sep; 8(3):319-21. PubMed ID: 11494062
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.